Role of the endothelium in viral hemorrhagic fevers - Benh Vien ...

Increased tumor necrosis factor-alpha levels
in Argentine hemorrhagic fever. J Infect Dis
1992; 166:1203–1204
9. de la Torre JC, Borrow P, Oldstone MB: Viral
persistence and disease: Cytopathology in the
absence of cytolysis. Br Med Bull 1991; 47:
838–851
10. Connolly BM, Jensen AB, Peters CJ, et al:
Pathogenesis of Pichinde virus infection in
strain 13 guinea pigs: An immunocytochemical,
virologic, and clinical chemistry study.
Am J Trop Med Hyg 1993; 49:10–24
11. Liu CT, Jahrling PB, Peters CJ: Evidence for
the involvement of sulfidopeptide leukotrienes
in the pathogenesis of Pichinde virus
infection in strain 13 guinea pigs. Prostaglandins
Leukot Med 1986; 24:129–138
12. Qian C, Ching-Tong L, Peters CJ: Increased
platelet-activating factor (PAF) concentrations
in hearts and lungs of Pichinde virusinfected
guinea pigs. J Lipid Mediat 1992;
5:261–270
13. Guo ZM, Liu CT, Peters CJ: Possible involvement
of endogenous beta-endorphin in the
pathophysiological mechanisms of Pichinde
virus-infected guinea pigs. Proc Soc Exp Biol
Med 1992; 200:343–348
14. Aronson JF, Herzog NK, Jerrells TR: Tumor
necrosis factor and the pathogenesis of
Pichinde virus infection in guinea pigs. Am J
Trop Med Hyg 1995; 52:262–269
15. Qian C, Jahrling PB, Peters CJ, et al: Cardiovascular
and pulmonary responses to
Pichinde virus infection in strain 13 guinea
pigs, Lab Anim Sci 1994; 44:600–607
16. Heller MV, Marta RF, Sturk A, et al: Early
markers of blood coagulation and fibrinolysis
activation in Argentine hemorrhagic fever.
Thromb Haemost 1995; 73:368–373
17. Fisher-Hoch S, McCormick JB, Sasso D, et al:
Hematologic dysfunction in Lassa fever.
J Med Virol 1988; 26:127–135
18. Cummins D, Fisher-Hoch SP, Walshe KJ, et
al: A plasma inhibitor of platelet aggregation
in patients with Lassa fever. Br J Haematol
1989; 72:543–548
19. Peters CJ: Pathogenesis of viral hemorrhagic
fevers. In: Viral Pathogenesis. Nathanson N,
Ahmed R, Gonzalez-Scarano F, et al (Eds).
Philadelphia, Lippincott-Raven, 1997, pp
779–799
20. Morrill JC, Jennings GB, Johnson AJ, et al:
Pathogenesis of Rift Valley fever in rhesus
monkeys: Role of interferon response. Arch
Virol 1990; 110:195–212
21. Cosgriff TM, Morrill JC, Jennings GB, et al:
The hemostatic derangement produced by
Rift Valley fever virus in rhesus monkeys.
Rev Infect Dis 1989; 11(Suppl 4):S807–S814
22. Swanepoel R, Gill DE, Shepherd AJ, et al: The
clinical pathology of Crimean-Congo hemorrhagic
fever. Rev Infect Dis 1989; 11(Suppl
4):S794–S800
23. Burt FJ, Swanepoel R, Shieh WJ, et al: Immunohistochemical
and in situ localization
of Crimean-Congo hemorrhagic fever virus
in human tissues and pathogenic implications.
Arch Pathol Lab Med 1997; 121:
839–846
24. Duchin JS, Koster FT, Peters CJ, et al: Hantavirus
pulmonary syndrome: A clinical description
of 17 patients with a newly recognized
disease. N Engl J Med 1994; 330:
949–955
25. Sundstrom JB, McMullan LK, Spiropoulou
CF, et al: Hantavirus infection induces the
expression of RANTES and IP-10 without
causing increased permeability in human
lung microvascular endothelial cells. J Virol
2001; 75:6070–6085
26. Zaki SR, Greer PW, Coffield LM, et al: Hantavirus
pulmonary syndrome: Pathogenesis
of an emerging infectious disease. Am J
Pathol 1995; 146:552–579
27. Mori M, Rothman AL, Kurane I, et al: High
levels of cytokine-producing cells in the lung
tissues of patients with fatal hantavirus pulmonary
syndrome. J Infect Dis 1999; 179:
295–302
28. Simpson SQ, Mapel V, Koster FT, et al: Evidence
for lymphocyte activation in the hantavirus
pulmonary syndrome. Chest 1995;
108:97S
29. Feldmann H, Klenk HD: Filoviruses: Marburg
and Ebola. In: Advances in Virus Research.
Vol. 47. Maramorosch K, Murphy FA,
Shatkin AJ (Eds). New York, Academic Press,
1996, pp 1–52
30. Zaki SR, Goldsmith CS: Pathologic features
of filovirus infections in humans. Curr Top
Microbiol Immunol 1999; 235:97–116
31. Villinger F, Rollin PE, Brar SS, et al: Markedly
elevated levels of interferon (IFN)-
gamma, IFN-alpha, interleukin (IL)-2, IL-10,
and tumor necrosis factor-alpha associated
with fatal Ebola virus infection. J Infect Dis
1999; 179:S188–S191
32. Feldmann H, Bugany H, Mahner F, et al:
Filovirus-induced endothelial leakage triggered
by infected monocytes/macrophages.
J Virol 1996; 70:2208–2214
33. Schnittler HJ, Feldmann H: Molecular
pathogenesis of filovirus infections: Role of
macrophages and endothelial cells. Curr Top
Microbiol Immunol 1999; 235:175–204
34. Geisbert TW, Hensley LE, Gibb TR, et al:
Apoptosis induced in vitro and in vivo during
infection by Ebola and Marburg viruses. Lab
Invest 2000; 80:171–196
35. Wali JP, Biswas A, Chandra S, et al: Cardiac
involvement in dengue haemorrhagic fever.
Int J Cardiol 1998; 64:31–36
36. Peters CJ, Simpson GL, Levy H: Spectrum of
hantavirus infection: Hemorrhagic fever
with renal syndrome and hantavirus pulmonary
syndrome. Annu Rev Med 1999; 50:
531–545
37. Wolbach SB: The etiology and pathology of
Rocky Mountain spotted fever. (Third Preliminary
Report.) The occurrence of the parasite
and the pathology of the disease in man.
Additional notes on the parasite. J Med Res
1917; 37:499–508
38. Chua KB, Bellini WJ, Rota PA, et al: Nipah
virus: A recently emergent deadly paramyxovirus.
Science 2000; 288:1432–1435
39. Grinberg LM, Abramova FA, Yampolskaya
OV, et al: Quantitative pathology of inhalation
anthrax I: Quantitative microscopic
findings. Mod Pathol 2001; 14:482–495
Crit Care Med 2002 Vol. 30, No. 5 (Suppl.)
S273